Entered strategic partnership with Otsuka Pharmaceutical Co., Ltd. for the development and commercialization of 4D-150 in the APAC region; to ...

Grant awards totaling more than $ 1.75 million will be distributed to 355 Oregon arts organizations through the Oregon Arts ...

Chicago schools are seeing a drop in attendance among English language learners amid the highly publicized U.S. Immigration ...

LYL273 has demonstrated a 67% overall response rate, an 83% disease control rate, and a manageable safety profile at the ...

The text was released on Sunday after weeks of negotiations between both parties in the House and Senate — and provides an off-ramp to end the shutdown.

R&D Expenses: Research and development expenses for the quarter ended September 30, 2025, were $9.4 million, compared to $9.7 million for the quarter ended September 30, 2024. The expenses were ...

CAMBRIDGE, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today ...

Dinesh Divakar from Alcatel-Lucent Enterprise talks about the company’s newest comms offering 1. What exactly is Rainbow Hub, and what does its launch in Australia/New Zealand bring to the local ...

Final negotiations on stopgap funding had been hampered by “ridiculous demands” made by Democrats, Sen. Markwayne Mullin, ...

Vance on a federal judge ordering the Trump administration to use emergency contingency funds to partially pay SNAP benefits: ...